Home/Filings/4/0000864268-04-000051
4//SEC Filing

BRADLEY PHARMACEUTICALS INC 4

Accession 0000864268-04-000051

CIK 0000864268operating

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 2:56 PM ET

Size

16.6 KB

Accession

0000864268-04-000051

Insider Transaction Report

Form 4
Period: 2004-04-07
GLASSMAN IRIS
DirectorTreasurer
Transactions
  • Discretionary Transaction

    Common Stock

    2004-04-07$1.31/sh+50,000$65,62589,692 total
  • Discretionary Transaction

    Stock Options (Right to buy)

    2004-04-07$1.31/sh50,000$65,6250 total
    Exercise: $1.31From: 1995-04-12Exp: 2004-04-11Common Stock (50,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    15,200
  • Stock Options (Right to buy)

    Exercise: $1.31From: 1997-12-30Exp: 2004-12-29Common Stock (50,000 underlying)
    50,000
  • Common Stock

    (indirect: By IRA)
    4,000
  • Stock Options (Right to buy)

    Exercise: $26.68From: 2006-11-11Exp: 2013-11-10Class B Common Stock (5,000 underlying)
    5,000
  • Stock Options (Right to buy)

    Exercise: $1.06From: 1995-12-05Exp: 2005-12-04Common Stock (22,878 underlying)
    22,878
  • Common Stock

    (indirect: By Trust)
    6,400
  • Stock Options (Right to buy)

    Exercise: $1.31From: 1998-09-12Exp: 2005-09-11Common Stock (18,000 underlying)
    18,000
  • Common Stock

    (indirect: By Trust)
    5,500
  • Stock Options (Right to buy)

    Exercise: $7.76From: 2004-07-09Exp: 2006-07-08Common Stock (30,000 underlying)
    30,000
  • Class B Common Stock

    16,403

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000864268

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 2:56 PM ET
Size
16.6 KB